Which hedge funds own ZBIO? ZENAS BIOPHARMA INC, Q2 2026 13F holders
35 tracked hedge funds disclosed a position in ZBIO (ZENAS BIOPHARMA INC) in their Q2 2026 13F filings, worth $320.9m in total. The largest holder by portfolio weight is NEXTBio Capital Management LP at 5.0% of its book. 7 opened a new position this quarter: Boothbay Fund Management, LLC, Verition Fund Management LLC, Y-Intercept (Hong Kong) Ltd, Brevan Howard Capital Management LP. 7 exited: Great Point Partners LLC, DAFNA Capital Management LLC, Fox Run Management, L.L.C..
- 35
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 7
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 7
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $4.2m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $13.9m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $321m
- Combined value Sum of the holders' reported positions in the security.
- 2.8%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Great Point Partners LLC | 2.5% | $10.2m |
| DAFNA Capital Management LLC | 0.2% | $831k |
| Fox Run Management, L.L.C. | 0.04% | $243k |
| Prelude Capital Management, LLC | 0.02% | $325k |
| Aquatic Capital Management LLC | 0.01% | $364k |
| Voloridge Investment Management, LLC | 0.01% | $1.5m |
| Schonfeld Strategic Advisors LLC | 0.0% | $345k |
Ownership over time
Who discovered ZBIO first? Beta
| Fairmount Funds Management LLC high conviction | Q3 2025 | +2.8 pts |
| Superstring Capital Management LP | Q3 2024 | +2.4 pts |
| Silverarc Capital Management, LLC | Q1 2026 | +0.8 pts |
| Birchview Capital, LP | Q1 2026 | +0.5 pts |
| EcoR1 Capital, LLC | Q4 2025 | −0.4 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.